1437 Harmony Lease Brochure...Title: 1437 Harmony Lease Brochure Created Date: 5/9/2020 11:53:21 AM
New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank ›...
Transcript of New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank ›...
![Page 1: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/1.jpg)
Prof Jakob R Passweg
New trends in donor selection in Europe: "best match" versus
haploidentical
![Page 2: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/2.jpg)
![Page 3: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/3.jpg)
Helen Baldomero2013 Activity Survey
HSCT – change in donor type: 1990-2015
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15
H
S
C
T
Year
HLA identical sibling/twin
Haplo-identical family
Unrelated
Cord blood
![Page 4: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/4.jpg)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0 12 24 36 48 60
S
u
r
v
i
v
a
l
Log-rank p-value = < 0.0001
8/8 HLA Matched (n=835)
7/8 HLA Matched (n=379)
Months after transplant
6/8 HLA Matched (n=241)
Impact of HLA mismatchesallogeneic Stem cell Transplantation
Lee et al BLood 2007Pedersdorf et al PLOS Med 2007 Takakau et al Blood 2007Shaw et al Blood 2008
Einfluss HLA match
![Page 5: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/5.jpg)
7/8 and 8/8 Allele, Available-Match Rates in the Adult Donor Registry
00.10.20.30.40.50.60.70.80.9
1
Cau
scas
ian
Nat
ive
Am
eric
an
His
pan
ic
Asi
an
Afr
ican
Am
eric
an
8 of 8 7 of 8
5
![Page 6: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/6.jpg)
The problem is not going away
![Page 7: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/7.jpg)
number of mismatches at HLA-A, B, C, DRB1/DQB1Effects cumulate
Morishima et al. Blood 2015; 125: 1189
![Page 8: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/8.jpg)
The German multicenter study (2646 patients, 1997-2010)
Any single mismatch at HLA-A,B,C or DRB1 loci confers a higher
mortality risk
Fürst et al. Blood 2013; 122: 3220
HLA-A,B,C,DRB1 mismatches are all relevant
![Page 9: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/9.jpg)
Single antigen or allele mismatches at
HLA-A,B,C,DRB1 confer the same mortality risk
Fürst et al. Blood 2013; 122: 3220
matched
Ag and allele
mismatched
Antigen versus allele (2 vs 4digit) mismatches
HLA A 0201 vs 0205HLA A 0201 vs 0301
![Page 10: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/10.jpg)
in 7/8 transplants: avoid >2 mismatches at the DRB3/4/5, DQ, DP loci
LEL
LowExpressionLoci
![Page 11: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/11.jpg)
avoid HLA-C MM with aasubstitution 116 or 99avoid HLA-B MM with aasubstitution 9G
VH
D I
II-I
V
Not all mismatchesAreEQUAL
![Page 12: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/12.jpg)
less immunogenic HLA class II mismatches
![Page 13: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/13.jpg)
10,462 8/8 HLA- Matched Unrelated DonorHLA-DQB1, HLA-DPB1 T-cell epitope matching)
![Page 14: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/14.jpg)
Fürst et al. Blood; 2013, 122: 3220
HSCT with national donors do better than with international donors
(lower proportion of patients with rare HLA phenotypes)
Fürst et al. Blood 2013; 122: 3220
![Page 15: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/15.jpg)
Progress?
• Haplotype matching?
• NK alloreactivity, activating KIR gene content?
• Matching low expression loci?
• Low expression loci expression regulation?
• T-cell epitope matching algorithms?
• Permissive mismatching e.g. HLA-C 0303 vs0304?
![Page 16: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/16.jpg)
Statistical Model Fitting = Overfitting
![Page 17: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/17.jpg)
Helen Baldomero2013 Activity Survey
0
500
1000
1500
2000
2500
90 92 94 96 98 00 02 04 06 08 10 12 14
H
S
C
T
Year
Haplo-identical Cord blood
HSCT Activity in Europe 1990-2015:
change in donor type
European Society for Blood and Marrow Transplantation Helen Baldomero2015 Activity Survey
![Page 18: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/18.jpg)
Choice of haploidentical Donors
![Page 19: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/19.jpg)
Results confirmed by many groups?
![Page 20: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/20.jpg)
aGvHD cGvHD
OS
![Page 21: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/21.jpg)
GvL in haploidentical HSCT
![Page 22: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/22.jpg)
GvL in haploidentical HSCT
![Page 23: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/23.jpg)
RelapseIncidence
![Page 24: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/24.jpg)
BuCy2 + ATG in HID
PB + BM in most
![Page 25: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/25.jpg)
Conclusion
• Unrelated donor transplantation -> successstory
• Haploidentical HCT without T-cell depletion -> success story
• Progress in MUD, better matching in low riskdisease, more GvL in hi risk disease?
• Progress in Haplo, maintain low TRM riskswhile improving GvL
![Page 26: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/26.jpg)
![Page 27: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/27.jpg)
HLA haplotype matching
Petersdorf et al. PLOS Med 2007; 4: 59-67
Increased risk of GVHD in haplotype-mismatchedunrelated HSCT (OR=4.5, p<0.0001)
Haplotypes that sharethe same HLA allelesmay also share discretesegments or blocks of highly conservedsequences in strongpositive linkage disequilibrium withthose HLA alleles
A1
B8
DR3
A2
B7
DR1
A2
B8
DR3
A1
B7
DR1
![Page 28: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/28.jpg)
Donor Selection Unrelated
• Match for A, B, C, DR
• Allele mismatch = antigen mismatch
• Single mismatches > multiple
• HLA DQB1 DRB3/4/5 more permissive
• Some permissive mismatches defined (C:0303 vs0304)
• Haplotype matching? KIR typing? HLA-DP typing? T-cell epitope matching algorithms? Low expression loci expression regulation?
![Page 29: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/29.jpg)
Characterization of “permissive” mismatches
➢ MM outside PBS (peptide binding site) or not seen
by TCR (ex: A*02:01/2:09, C*03:03/03:04, DRB1*14:01/14:54, …)
but indirect recognition ??
➢ MM associated with a negative in vitro functional
assay (MLC, CTLp) (ex: DRB1*11:01/11:04, DQB1*03:01/03:02, …)
➢ avoid specific aa MM in PBS (aa 9, 99, 116)
Pasi et al. BMT 2011; 46: 916
Jöris et al. Transpl. Immunol. 2014; 30: 59
Fernandez-Vina et al. Blood 2013; 121: 4603
Pidala et al. Blood 2013; 122: 3651
![Page 30: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/30.jpg)
HLA-DPB1 mismatches are detrimental
Petersdorf et al. BJH 2001Loiseau et al. BMT 2002Shaw et al. Blood 2007 (GVHD, no OS)Ludajic et al. BJH 2008Crocchiolo et al. Blood 2009Shaw et al. Leukemia 2010 (TCD, early disease, OS)Bettens et al. BBMT 2012Pidala et al. Blood 2014
DPB1 matching
![Page 31: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/31.jpg)
5929 patients (IHWG study)
DPB1 MM: aGVHD II-IV riskOR = 1.33 (P<0.001)no impact on OS
![Page 32: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/32.jpg)
488 TCD patientsDifferential impact of DPB1 MM in early vs late disease
![Page 33: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/33.jpg)
early late
early late
10/10
≤9/10
![Page 34: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/34.jpg)
The ‘’Italian’’ matching algorithm
DPB1*
09:0110:0117:01
03:0114:0145:01
others
TCE
1
2
3
immunogenicity
adapted from Crocchiolo et al.Blood 2009; 114: 1437
permissive
Non-permissive
![Page 35: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/35.jpg)
IHWG study5428 10/10 matched patients3111 9/10 matched patients
DPB1 matched 20%non-permissive MM (31%)permissive MM (49%)
![Page 36: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/36.jpg)
10/10
9/10
![Page 37: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/37.jpg)
10/10 matched patientsnon-perm. MM => overall mortality HR=1.15 (p=0.002) compared with perm. MM
Match vs. perm. MM: non-relapse mortality and relapse, but no impact on overall mortality
9/10 matched patients:Non-perm. vs. perm. MM: non-relapse mortality and aGVHD
![Page 38: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/38.jpg)
Outcome for 10/10 matched transplantations with non-permissive HLA-DPB1 mismatches did not differ substantially from those for HLA 9/10-matched transplantation with permissive HLA-DPB1 mismatches or HLA-DPB1 matches
If one consider a 9/10 matched donor, look for a donor with a DPB1 match or with a permissive DPB1 MM
![Page 39: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/39.jpg)
![Page 40: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/40.jpg)
8/8
DQB1 MM: no impact
DPB1 MM:aGVHD, relapse(both permissive and non-perm. MM)
![Page 41: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/41.jpg)
Pidala et al. Blood 2014; 124: 2596
![Page 42: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/42.jpg)
rs9277534 in the regulatory region of HLA-DPB1 is associated with DPB1 expression
![Page 43: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/43.jpg)
DPB1*02/04/17
DPB1*01/03/05/06/10/11
DPB1*02/04/17
Look for donors matched for
the high expression allele
rs9277534G-linked MM (high DP) => detrimental effect only when MM linked to donor rs9277534A (low DP)
![Page 44: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/44.jpg)
low
high
![Page 45: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/45.jpg)
Related/unrelated HSCT with fully matched donors:
minor histocompatibility Ag presented by high expression
DPB1 alleles may be more efficiently recognized by
alloreactive T cells
![Page 46: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/46.jpg)
Indirect allorecognition of HLA mismatched alleles: the PIRCHE model
PIRCHE = predicted indirectly recognizable HLA epitopesIn silico prediction of the numbers of peptides derived from mismatched HLA alleles that can be presented by shared HLA antigens, correlation between increasing nb of PIRCHES and increased risk of alloreactivity
![Page 47: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/47.jpg)
![Page 48: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/48.jpg)
HLA haplotype matching
Petersdorf et al. PLOS Med 2007; 4: 59-67
Increased risk of GVHD in haplotype-mismatchedunrelated HSCT (OR=4.5, p<0.0001)
Haplotypes that sharethe same HLA allelesmay also share discretesegments or blocks of highly conservedsequences in strongpositive linkage disequilibrium withthose HLA alleles
A1
B8
DR3
A2
B7
DR1
A2
B8
DR3
A1
B7
DR1
![Page 49: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/49.jpg)
Horton et al. Nat. Rev. Genet. 2004; 5: 889
HLA-A
HLA-DP
MHC=253 genes
HLA-DR
HLA-B
HLA-C
HLA-DQ
![Page 50: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/50.jpg)
2628 HLA mismatched HSCTs25% HLA-A MM13% HLA-B MM38% HLA-C MM6% HLA-DRB1 MM17% HLA-DQB1 MM
Each SNP tested 3 ways: patient genotype, donorgenotype, patient/donor SNP mismatching
Clinical endpoints:GVHD II-IV, GVHD II-IV, cGVHD, TRM, relapse (malignancies), DFS, survival
![Page 51: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/51.jpg)
12 SNPs of clinical significance in HLA-mismatched HSCT
HLA-DOA, NOTCH4, TRIM27, FKBPL, HCP5, COL11A2, HSPA1L, BAG6, LTA, RING1
![Page 52: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/52.jpg)
Genetic variation linked to specific HLA haplotypesmay impact clinical outcome
DPA DR/DQC Bpatient
donor
DPA DR/DQC Bpatient
donor23%
53%
SNP mismatch
FrequentHaplotype
No FH
SNP = single nucleotide poylmorphism
![Page 53: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/53.jpg)
patients with frequent/conserved HLA haplotypes (high probability to find a fully compatible unrelated HSC donor)
012
Jöris et al. BMT 2013
322 p
p=0.01
high
interm./low
205 p
Tiercy et al. BMT 2007
higher survival lower GVHD incidence
![Page 54: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/54.jpg)
Einwohner Spender
Israel 7’600’000 546’851
Schweiz 7’800’000 100‘000
![Page 55: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/55.jpg)
![Page 56: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/56.jpg)
![Page 57: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/57.jpg)
![Page 58: New trends in donor selection in Europe: best match versus ... › de › wissensdatenbank › ... · TCE 1 2 3 immunogenicity. adapted from Crocchiolo et al. Blood 2009; 114: 1437.](https://reader033.fdocuments.us/reader033/viewer/2022042408/5f2401127ec27d39c4617bb9/html5/thumbnails/58.jpg)
The concept of low expression loci (LEL) mismatchesLEL = DQA1/DQB1, DPA1/DPB1, DRB3/4/5
DP DQ DR B C A
B1 A1 B1 A1 A1B1 B3B4B5